moxifloxacin has been researched along with duloxetine hydrochloride in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (duloxetine hydrochloride) | Trials (duloxetine hydrochloride) | Recent Studies (post-2010) (duloxetine hydrochloride) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,887 | 441 | 1,073 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callaghan, JT; Chappell, J; Derby, M; Desaiah, D; Ereshefsky, L; Francis, JL; Gonzales, CR; Hoelscher, D; Knadler, MP; Leese, PT; Leibowitz, M; Small, D; Zhang, L | 1 |
1 trial(s) available for moxifloxacin and duloxetine hydrochloride
| Article | Year |
|---|---|
QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Infective Agents; Antidepressive Agents; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Electrocardiography; Female; Fluoroquinolones; Guideline Adherence; Humans; Middle Aged; Moxifloxacin; Practice Guidelines as Topic; Quinolines; Thiophenes | 2007 |